CCMINC
Cardinal Capital Management Inc (North Carolina) Portfolio holdings
AUM
$681M
1-Year Return
15.1%
This Quarter Return
+3.46%
1 Year Return
+15.1%
3 Year Return
+57.39%
5 Year Return
+116.47%
10 Year Return
+269.09%
AUM
$352M
AUM Growth
+$2.39M
(+0.68%)
Cap. Flow
-$5.79M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
134
New
6
Increased
26
Reduced
91
Closed
6
Top Buys
| 1 |
Dow Inc
DOW
|
+$1.17M |
| 2 |
NXP Semiconductors
NXPI
|
+$775K |
| 3 |
Corteva
CTVA
|
+$709K |
| 4 |
Alcon
ALC
|
+$537K |
| 5 |
Eastern Company
EML
|
+$528K |
Top Sells
| 1 |
UBS Group
UBS
|
+$1.23M |
| 2 |
DuPont de Nemours
DD
|
+$885K |
| 3 |
Sally Beauty Holdings
SBH
|
+$661K |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$549K |
| 5 |
Novartis
NVS
|
+$492K |
Sector Composition
| 1 | Healthcare | 21.4% |
| 2 | Technology | 19.2% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Staples | 12.88% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teledyne Technologies
TDY
$26.1B
| $1.46M | 0.41% |
5,332
-203
| -4% | -$55.6K |
|
77
Phillips 66
PSX
$52.9B
| $1.44M | 0.41% |
15,426
-120
| -0.8% | -$11.2K |
|
78
Robert Half
RHI
$3.61B
| $1.41M | 0.4% |
24,730
-719
| -3% | -$41K |
|
79
Banco Santander Chile
BSAC
$12.1B
| $1.31M | 0.37% |
43,931
-298
| -0.7% | -$8.91K |
|
80
United States Lime & Minerals
USLM
$3.63B
| $1.31M | 0.37% |
81,705
+450
| +0.6% | +$7.2K |
|
81
CACI
CACI
$10.9B
| $1.23M | 0.35% |
5,995
-221
| -4% | -$45.2K |
|
82
Oil-Dri
ODC
$959M
| $1.23M | 0.35% |
72,032
+906
| +1% | +$15.4K |
|
83
Snap-on
SNA
$17.4B
| $1.21M | 0.34% |
7,286
+63
| +0.9% | +$10.4K |
|
84
Badger Meter
BMI
$5.24B
| $1.2M | 0.34% |
20,083
-1,106
| -5% | -$66K |
|
|
85
Dow Inc
DOW
$17.7B
| $1.17M | 0.33% |
+23,812
| New | +$1.17M |
|
86
Charles River Laboratories
CRL
$7.52B
| $1.17M | 0.33% |
8,235
-203
| -2% | -$28.8K |
|
87
Boston Beer
SAM
$2.36B
| $1.14M | 0.32% |
3,029
-231
| -7% | -$87.2K |
|
88
Grifois
GRFS
$6.72B
| $1.13M | 0.32% |
53,312
+119
| +0.2% | +$2.51K |
|
89
Graco
GGG
$14B
| $1.12M | 0.32% |
22,340
-517
| -2% | -$25.9K |
|
90
Curtiss-Wright
CW
$19.2B
| $1.1M | 0.31% |
8,644
-157
| -2% | -$20K |
|
91
John Wiley & Sons Class A
WLY
$2.19B
| $1.03M | 0.29% |
22,348
+215
| +1% | +$9.86K |
|
92
Integra LifeSciences
IART
$1.17B
| $991K | 0.28% |
17,749
-237
| -1% | -$13.2K |
|
93
Haemonetics
HAE
$2.51B
| $975K | 0.28% |
8,102
-158
| -2% | -$19K |
|
94
Utah Medical Products
UTMD
$200M
| $950K | 0.27% |
9,924
-239
| -2% | -$22.9K |
|
95
Alphabet (Google) Class C
GOOG
$2.92T
| $925K | 0.26% |
17,120
-80
| -0.5% | -$4.32K |
|
|
CDK
96
DELISTED
CDK Global, Inc.
CDK
| $917K | 0.26% |
18,553
+29
| +0.2% | +$1.43K |
|
97
Monro
MNRO
$519M
| $914K | 0.26% |
10,715
-342
| -3% | -$29.2K |
|
|
FLIR
98
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $895K | 0.25% |
16,551
-566
| -3% | -$30.6K |
|
99
FNB Corp
FNB
$5.89B
| $884K | 0.25% |
75,124
| – | – |
|
100
GSK
GSK
$82.2B
| $853K | 0.24% |
17,054
+72
| +0.4% | +$3.6K |
|